Loading...

358 posters, 97 topics, 122 sessions, 958 authors, 239 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

79th PostGraduate Assembly in Anesthesiology 2025

December 12 - 15, 2025 | New York City

79th PostGraduate Assembly in Anesthesiology 2025 banner

3092

The effect of perioperative multimodal adjunct analgesics on postoperative pulmonary complications and opioid requirements: A retrospective cohort study

Part of Topic

Pain Medicine

BACKGROUND

  • Postoperative pain is a strong predictor of patient dissatisfaction, has been linked to prolongedhospitalization and higher risks of postoperative pulmonary complications (PPC) [1]

  • Multimodal adjunct analgesics (MAA) target various nociceptive pathways, reducing opioid use,possibly lowering PPC risk [2,3]

  •  

HYPOTHESIS

  • The use of perioperative MAA is associated with a lower risk of PPC, possibly mediated by lowerperioperative opioid requirements.

SETTING AND STUDY POPULATION

  • 62,265 adults undergoing non-ambulatory, non-emergent, non-cardiac surgery under general anesthesia with PACU admission (2014–2024, Beth Israel Deaconess Medical Center, Boston, Figure 1)

  •  

EXPOSURE

  • MAA defined as ≥2 non-opioid analgesics given perioperatively in preoperative holding area or operating room

OUTCOMES

  • Primary: PPC; composite of reintubation, emergency non-invasive ventilation and pneumonia ≤7 days

  • Secondary: opioid requirements intraoperatively and in PACU (presented in oral morphine equivalents OME) and postextubation desaturation

  •  

STATISTICAL ANALYSIS

  • Multivariable logistic and zero-inflated negative binomial regression, adjusted for patient, procedural, and anesthetic factors (Table 1)

 
RESULTS
  • No overall risk reduction of PPC (ORadj 0.98; 95%CI 0.88-1.11, p=0.79, Figure 2)

  • Reduced requirements of perioperative opioids (excluding remifentanil, Figure 2)

  • Benefits were especially pronounced in younger and healthier patients as well aslonger and more complex procedures (Table 2)

  • Lower risk of postextubation desaturation (n= 46,061, ORadj 0.82; 95%CI 0.75 -0.90; p< 0.001)

CONCLUSION
MAA was associated with reduced perioperative opioid requirements and a decreased risk of postextubation desaturation, but notwith overall PPC risk reduction. These effects were more pronounced in selected procedures and patient subgroups.
pga2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.